Uri Weinberg

CIK: 0001811030

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (66.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NVCR

NovoCure Ltd

Officer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

NVCR
NovoCure Ltd
Mar 4, 2026
Sale(S)
Direct
6.4K shares at avg. $13.31$85K
NVCR
NovoCure Ltd
Mar 3, 2026
Award(A)
Direct
50.1K shares-
NVCR
NovoCure Ltd
Mar 2, 2026
Sale(S)
Direct
3.3K shares at avg. $13.33$44K
NVCR
NovoCure Ltd
Feb 28, 2026
Award(A)
Direct
13K shares-
NVCR
NovoCure Ltd
Feb 27, 2026
Sale(S)
Direct
7.5K shares at avg. $13.84$103K
NVCR
NovoCure Ltd
Mar 4, 2025
Award(A)
Direct
55K shares at avg. $18.19$1000K
NVCR
NovoCure Ltd
Mar 3, 2025
Sale(S)
Direct
268 shares at avg. $18.92$5K
NVCR
NovoCure Ltd
Feb 28, 2025
Sale(S)
Direct
311 shares at avg. $18.31$6K
NVCR
NovoCure Ltd
Feb 28, 2025
Sale(S)
Direct
4.3K shares at avg. $18.78$81K

		Type	Shares	Price		Ownership
Mar 4, 2026	NVCR NovoCure Ltd	Sale(S)	6,412	$13.31	$85,314	Direct
Mar 3, 2026	NVCR NovoCure Ltd	Award(A)	50,125	-	$0	Direct
Mar 2, 2026	NVCR NovoCure Ltd	Sale(S)	3,272	$13.33	$43,607	Direct
Feb 28, 2026	NVCR NovoCure Ltd	Award(A)	12,992	-	$0	Direct
Feb 27, 2026	NVCR NovoCure Ltd	Sale(S)	7,461	$13.84	$103,257	Direct
Mar 4, 2025	NVCR NovoCure Ltd	Award(A)	54,975	$18.19	$999,995	Direct
Mar 3, 2025	NVCR NovoCure Ltd	Sale(S)	268	$18.92	$5,071	Direct
Feb 28, 2025	NVCR NovoCure Ltd	Sale(S)	311	$18.31	$5,695	Direct
Feb 28, 2025	NVCR NovoCure Ltd	Sale(S)	4,326	$18.78	$81,254	Direct

1-9 of 9 transactions

About Weinberg Uri

Weinberg Uri (SEC CIK 0001811030) files insider reports with the SEC as Chf Medical and Innovation Ofr of NovoCure Ltd (NVCR).

Signal8 holds 6 ownership filings by Weinberg Uri, all Form 4s, filed between Mar 3, 2025 and Mar 5, 2026. Those filings report 9 transactions, from Feb 28, 2025 to Mar 4, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Weinberg Uri's filings is in WAYNE, PA.

Recent filings by Weinberg Uri

Mar 4, 2026: Open-market sale of NVCR shares (Form 4, code S).
Mar 3, 2026: Grant or award of NVCR shares (Form 4, code A).
Mar 2, 2026: Open-market sale of NVCR shares (Form 4, code S).
Feb 28, 2026: Grant or award of NVCR shares (Form 4, code A).
Feb 27, 2026: Open-market sale of NVCR shares (Form 4, code S).

Other insiders filing for NovoCure Ltd (NVCR)

Puri Michal Nath, Chief Human Resources Officer
Leonard Frank X, Chief Executive Officer
Ben Arye Barak, General Counsel
Danziger Asaf, Director
LEUNG GABRIEL, Director
Stafford Kristin, Director

How to read Form 4 transaction codes